These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2455131

  • 1. Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.
    Sato T, Nara Y, Note S, Yamori Y.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S192-4. PubMed ID: 2455131
    [Abstract] [Full Text] [Related]

  • 2. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G.
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [Abstract] [Full Text] [Related]

  • 3. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
    Amazonas RB, Lopes de Faria JB.
    Life Sci; 2006 Oct 26; 79(22):2135-43. PubMed ID: 16890245
    [Abstract] [Full Text] [Related]

  • 4. Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats.
    Rosenthal T, Rosenmann E, Tomassoni D, Amenta F.
    J Cardiovasc Pharmacol Ther; 2007 Jun 26; 12(2):145-52. PubMed ID: 17562785
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR, Doyle AE, Cooper ME.
    Am J Hypertens; 1995 Jan 26; 8(1):53-7. PubMed ID: 7734098
    [Abstract] [Full Text] [Related]

  • 6. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M, Chopra K.
    Ren Fail; 2005 Jan 26; 27(3):335-44. PubMed ID: 15957552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov 26; 38(11A):1684-90. PubMed ID: 3064752
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus.
    Kusaka-Nakamura M, Kishi K, Miyazawa A, Yagi S, Sokabe H.
    Acta Physiol Hung; 1988 Nov 26; 71(2):251-69. PubMed ID: 3291554
    [Abstract] [Full Text] [Related]

  • 11. Antiischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic, and hypertensive rats.
    Pijl AJ, Hendriks MG, Kam KL, Pfaffendorf M, van Zwieten PA.
    J Cardiovasc Pharmacol; 1994 Mar 26; 23(3):379-86. PubMed ID: 7515980
    [Abstract] [Full Text] [Related]

  • 12. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec 26; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 13. Neonatal streptozotocin-induced glucose intolerance: different consequences in Lyon normotensive and hypertensive rats.
    Emonnot L, Cohen R, Lo M.
    J Hypertens; 2007 Feb 26; 25(2):429-38. PubMed ID: 17211251
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K.
    J Hypertens; 1995 Jan 26; 13(1):97-103. PubMed ID: 7759858
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
    Hakim ZS, Goyal RK.
    Indian J Physiol Pharmacol; 2000 Apr 26; 44(2):125-35. PubMed ID: 10846625
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ, Dworkin LD, Ma J, Lango MN, Catanese VM.
    J Investig Med; 1997 Dec 26; 45(9):584-91. PubMed ID: 9444886
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr 26; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 18. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr 26; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T, Kanazawa T, Ito K, Nose T.
    Arzneimittelforschung; 1982 Apr 26; 32(9):1047-52. PubMed ID: 6890824
    [Abstract] [Full Text] [Related]

  • 20. Effect of hypertension on the development of diabetic cardiomyopathy.
    Mathis DR, Liu SS, Rodrigues BB, McNeill JH.
    Can J Physiol Pharmacol; 2000 Oct 26; 78(10):791-8. PubMed ID: 11077979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.